US launches Section 301 probe into Germany over drug pricing
The US has launched an investigation under Section 301 of the Trade Act of 1974 against Germany over alleged underpayment for innovative pharmaceutical products.
- Country:
- United States
The United States has initiated an investigation under Section 301 of the Trade Act of 1974 against Germany, U.S. Trade Representative Jamieson Greer said on Thursday.
The investigation will seek to determine whether persistent underpayment for innovative pharmaceutical products by Germany is unreasonable or discriminatory, the USTR said.
ALSO READ
-
US launches trade investigation into Germany over drug pricing
-
US launches Section 301 probe into Germany over drug pricing
-
Carney says Canada, US held detailed, technical trade talks at G7
-
Soccer-Germany keeper Neuer will retire from national team again after World Cup
-
FTC requiring Aurobindo Pharma to divest from four drug products to complete acquistion of Lannett
Google News